U.S., April 7 -- ClinicalTrials.gov registry received information related to the study (NCT07511491) titled 'Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section' on March 28.
Brief Summary: This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
Study Start Date: April 10
Study Type: INTERVENTIONAL
Condition:
Ondansetron
Lozenge
Intravenous
Prevention
Shivering
Cesarean Section
Intervention:
DRUG: Ondansetron lozenge
Patients will receive ondansetron lozenge 4 mg (Ondalenz (c)), 2 hours before surgery.
DRUG: Ondansetron intravenous
Patients will receive 8 mg of ondansetron IV just before the surgery.
Recruitment Status: N...